Lotus Health AI, Inc.

Lotus Health AI, Inc. is a US-based innovator in digital healthcare, utilizing artificial intelligence to enhance primary care services and patient engagement with a focus on accessibility and affordability. Based in Covina, US, Lotus Health AI, Inc, Co founded by Zekka Nelson and KJ Dhaliwal, also serving as CEO as of 2026, in 2024 specializes in integrating AI with healthcare services to improve patient outcomes. The company has successfully closed two deals, raising USD 35 mn in Series A funding on February 3, 2026, with investors including CRV, Kleiner Perkins, LEAD, and Liquid 2 Ventures.

The current company valuation stands at USD 126. 20 mn. Lotus Health AI offers a digital healthcare platform that merges artificial intelligence with input from medical professionals to provide comprehensive primary care. The AI-driven application enables users to consult healthcare providers anytime, manage prescriptions at no cost, and access personalized health records, targeting patients across major US regions including California.

The revenue model of Lotus Health AI is based on strategic partnerships rather than direct consumer transactions. By offering free services to patients, the company cultivates a broad user base, generating revenue through collaborations with healthcare entities that utilize the platform for patient management and analytics services. Following the Series A funding of USD 35 mn raised in February 2026, Lotus Health AI plans to expand its clinical operations, enhance its technology, and scale patient outreach initiatives. The company is targeting further growth in new markets and regions across the United States, with specific timelines for product releases and expansions yet to be disclosed.